Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibitionLei Gao, Liang Chen, Guang‐Biao Zhou et al.|Nature Communications|2019Cited by 68
Integrative study of lung cancer adeno-to-squamous transition in EGFR TKI resistance identifies RAPGEF3 as a therapeutic targetHua Wang, Hongbin Ji, Cai‐Guang Yang et al.|National Science Review|2024Cited by 7